Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1942 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.31 USD | -2.04% | +6.05% | +5.43% | +36.71% | 2.17 B USD | ||
| 1949 | ADMA ADMA Biologics Inc - Common Stock | 9.72 USD | -1.22% | +2.10% | +15.99% | -44.90% | 2.18 B USD | ||
| 1954 | VCEL Vericel Corporation - Common Stock | 42.66 USD | -0.05% | -3.05% | -6.20% | +17.36% | 2.18 B USD | ||
| 1961 | MESO Mesoblast Limited - American Depositary Shares | 16.44 USD | -3.29% | -3.92% | +9.75% | +2.75% | 2.10 B USD | ||
| 1978 | NBTX Nanobiotix S.A. - ADSs | 39.72 USD | -8.79% | +0.28% | -0.10% | +321.66% | 1.92 B USD | ||
| 1979 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.24 USD | -3.25% | +6.01% | +1.07% | +18.07% | 2.04 B USD | ||
| 1985 | BHVN Biohaven Ltd. Common Shares | 13.74 USD | -0.79% | -4.45% | -6.78% | -18.89% | 2.08 B USD | ||
| 1987 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.75 USD | -1.67% | +1.37% | +7.34% | +62.49% | 2.05 B USD | ||
| 1991 | XNCR Xencor, Inc. - Common Stock | 27.28 USD | -1.87% | +17.28% | +40.04% | +225.54% | 2.03 B USD | ||
| 2008 | ZYME Zymeworks Inc. - Common Stock | 27.30 USD | -4.78% | +8.59% | +18.34% | +53.89% | 1.94 B USD | ||
| 2018 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.19 USD | -3.19% | +0.94% | +10.44% | -10.13% | 1.92 B USD | ||
| 2020 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.87 USD | -3.61% | -2.33% | +3.71% | +95.67% | 1.91 B USD | ||
| 2026 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.07 USD | -0.06% | -0.87% | -8.72% | -23.78% | 1.97 B USD | ||
| 2045 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.04 USD | -2.28% | +5.91% | +2.80% | +7.65% | 1.86 B USD | ||
| 2054 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -5.71% | +6.11% | +8.55% | -34.00% | 1.77 B USD | ||
| 2057 | SEPN Septerna, Inc. - Common Stock | 40.34 USD | +0.85% | -9.96% | +21.32% | +83.28% | 1.88 B USD | ||
| 2077 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.40 USD | -3.43% | +4.20% | +12.01% | -9.62% | 1.74 B USD | ||
| 2098 | GHRS GH Research PLC - Ordinary Shares | 27.45 USD | -3.11% | -6.41% | -1.47% | +93.86% | 1.70 B USD | ||
| 2099 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.26 USD | -1.98% | -2.28% | -8.68% | +18.45% | 1.72 B USD | ||
| 2103 | FTRE Fortrea Holdings Inc. - Common Stock | 18.27 USD | -0.65% | +4.70% | -6.36% | +119.06% | 1.74 B USD |
Notícias Biotechnology Stocks
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
FDA prorroga revisão do deramiocel da Capricor para novembro de 2026
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |